We are live on ! Find out more
RNAM

Avidity Biosciences
RNAM

Delisted

RNAM was delisted on the 26th of February, 2026.

Back to rankings

103 hedge funds and large institutions have $1.09B invested in Avidity Biosciences in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 27 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

54,300% more call options, than puts

Call options by funds: $2.72M | Put options by funds: $5K

26% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 27

10.07% more ownership

Funds ownership: 96.85% → 106.91% (+10%)

1% more capital invested

Capital invested by funds: $1.08B → $1.09B (+$5.92M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4% less funds holding

Funds holding: 107 → 103 (-4)

21% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 19

Holders
103
Holders Change
-4
Holders Change %
-3.74%
% of All Funds
1.62%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
34
Reduced
27
Closed
19
Calls
$2.72M
Puts
$5K
Net Calls
+$2.71M
Net Calls Change
+$2.72M

Top Buyers

Rank Fund Capital Flow
1
AWA
Aaron Wealth Advisors
Illinois
+$64M
2
RCM
RA Capital Management
Massachusetts
+$29.6M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$5.01M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$4.31M
5
State Street
State Street
Massachusetts
+$4.15M

Top Sellers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
-$23.8M
2
WP
Woodline Partners
California
-$3.04M
3
FAM
Fred Alger Management
New York
-$2.55M
4
OCA
Octagon Capital Advisors
New York
-$2.12M
5
US Bancorp
US Bancorp
Minnesota
-$1.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
26
Artal Group
Luxembourg
$4.62M – – –
ACM
27
Altium Capital Management
New York
$4.49M +$306K +18,000 +8%
CS
28
Candriam SCA
Luxembourg
$2.96M – – –
TD Asset Management
29
TD Asset Management
Ontario, Canada
$2.64M -$89.3K -5,258 -4%
AllianceBernstein
30
AllianceBernstein
Tennessee
$2.62M -$90.2K -5,307 -4%
Walleye Capital
31
Walleye Capital
New York
$2.58M +$2.37M +139,635 New
Bank of New York Mellon
32
Bank of New York Mellon
New York
$2.52M +$12.2K +719 +0.5%
Deutsche Bank
33
Deutsche Bank
Germany
$2.26M -$41.1K -2,422 -2%
Goldman Sachs
34
Goldman Sachs
New York
$2.25M +$198K +11,659 +11%
Morgan Stanley
35
Morgan Stanley
New York
$2.02M +$587K +34,555 +46%
N
36
Nuveen
North Carolina
$1.99M -$21K -1,238 -1%
JP Morgan Chase
37
JP Morgan Chase
New York
$1.87M -$174K -10,256 -9%
UBS Group
38
UBS Group
Switzerland
$1.68M +$147K +8,638 +11%
Swiss National Bank
39
Swiss National Bank
Switzerland
$1.54M +$136K +8,000 +11%
Wells Fargo
40
Wells Fargo
California
$1.5M -$760K -44,761 -36%
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.49M +$1.06M +62,375 +316%
Rafferty Asset Management
42
Rafferty Asset Management
New York
$1.44M +$231K +13,620 +21%
US Bancorp
43
US Bancorp
Minnesota
$1.27M -$1.17M -69,041 -50%
Los Angeles Capital Management
44
Los Angeles Capital Management
California
$1M – – –
HS
45
HighVista Strategies
Massachusetts
$982K +$151K +8,870 +20%
Barclays
46
Barclays
United Kingdom
$947K +$872K +51,326 New
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$852K +$32.8K +1,932 +4%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$848K -$55.2K -3,252 -7%
HCA
49
Harbor Capital Advisors
Illinois
$839K -$190K -11,209 -20%
Bank of America
50
Bank of America
North Carolina
$788K -$789K -46,452 -52%
1
2
3 4 5

RNAM Hedge Fund Activity: Q1 2022 in Review

103 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Avidity Biosciences (RNAM) for Q1 2022, worth a combined $1.09B — up 0.55% from $1.08B a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of RNAM and 15 opened new positions — a net loss of 4 holders — while 27 trimmed existing stakes and 34 added.

The largest buyer was Aaron Wealth Advisors, adding an estimated $64M. The largest seller was Deep Track Capital, exiting entirely with an estimated $23.8M sold.

  • 103 institutional investors held Avidity Biosciences (RNAM) as of Q1 2022, down from 107 in Q4 2021.
  • Funds reported $1.09B of Avidity Biosciences stock for Q1 2022, up 0.55% quarter-over-quarter.
  • 15 funds opened new Avidity Biosciences positions in Q1 2022 and 19 closed out, a net change of -4 holders.
  • The largest Avidity Biosciences buyer in Q1 2022 was Aaron Wealth Advisors, an estimated $64M added.
  • The largest Avidity Biosciences seller in Q1 2022 was Deep Track Capital, an estimated $23.8M sold.

Based on aggregated 13F filings for Q1 2022.